By December 1, 1992, the MO HealthNet division shall, either directly or through contract with a private organization, provide for a prospective review of drug therapy. The review shall include screening for potential drug therapy problems, duplication, contraindications, interactions, incorrect drug dosage, drug allergy, duration of therapy and clinical abuse or misuse.
Mo. Rev. Stat. § 208.176
Division to provide for prospective review of drug therapy
Known as the Missouri Long-term Care Partnership Program Act
The act spans §§ 208–208 (229 sections).
Effective: 28 Aug 2014, 2 histories; (L. 1992 S.B. 721 § 4, A.L. 2014 H.B. 1299 Revision)
Official source: Missouri Revisor of Statutes. Reproduced from public-domain Missouri statutes; confirm against the official source for the current text. Not legal advice.